Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
120
datasets available to search
ShareScore release 0.9.0
Dataset results
120 results for “Vascular endothelial growth factor”
Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept
ClinicalTrials.gov study NCT02125864. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer
ClinicalTrials.gov study NCT00827372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy
ClinicalTrials.gov study NCT01141569. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00775411. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
ClinicalTrials.gov study NCT00879359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vascular Endothelial Growth Factor (VEGF) in Uveitis
ClinicalTrials.gov study NCT00001738. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
ClinicalTrials.gov study NCT00607477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration
ClinicalTrials.gov study NCT01988662. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
ClinicalTrials.gov study NCT02257632. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
ClinicalTrials.gov study NCT02712008. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
ClinicalTrials.gov study NCT02713204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Significant correlation between retinal venous tortuosity and aqueous vascular endothelial growth factor concentration in eyes with central retinal vein occlusion
Open the record for dataset details and reuse information.
PI3K-mediated crosstalk between angiopoietin and vascular endothelial growth factor C signaling pathways is required for lymphangiogenesis
GEO Series GSE202989. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
RNA sequencing of pancreatic islet-derived beta cells, macrophages, and endothelial cells modulated by vascular endothelial growth factor-A signaling
GEO Series GSE163825. Mus musculus. 32 samples. Type: Expression profiling by high throughput sequencing.
Iodide Inhibits Vascular Endothelial Growth Factor-A Expression in Cultured Human Thyroid Follicles
GEO Series GSE12244. Homo sapiens. 2 samples. Type: Expression profiling by array.
RNA sequencing of pancreatic islets and islet-derived macrophages and endothelial cells modulated by vascular endothelial growth factor-A signaling
GEO Series GSE72546. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Identification of HGF/c-MET as a biomarker of resistance to Vascular Endothelial Growth Factor Receptor (VEGFR) inhibitors
GEO Series GSE64472. Homo sapiens; Mus musculus. 22 samples. Type: Expression profiling by array.
Intracrine Vascular Endothelial Growth Factor Maintains Hippocampal Neural Stem Cell Quiescence
GEO Series GSE220871. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.
Data from: Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Objective: To explore the association of peripheral neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) use in cancer patients. Methods: Published data search up to November 2018 reporting peripheral neuropathy in cancer patients treated with VEGFR-TKIs was performed. The primary outcome was presence of peripheral neuropathy at the end of the trial. Random-effects meta-analysis was performed to estimate Relative Risk (RR) of individual treatment. Results: Thirty Randomized Clinical Trials (RCTs) including 12,490 cancer patients were included in this analysis. Eight studies compared VEGFR-TKIs with placebo and the remaining studies compared VEGFR-TKIs with the standard chemotherapeutic regimen. When compared against placebo VEGFR-TKIs were associated with a higher risk of peripheral neuropathy (RR=1.76, 95% CI 1.13-2.75, p-value 0.01). Similarly, a stronger association was noted for sensory neuropathy with VEGFR-TKIs monotherapy (RR = 1.61; 95% CI 1.09-2.37, p = 0.02). Risk of peripheral neuropathy with VEGFR-TKIs was higher even when they were compared against control (either placebo or standard chemotherapeutic agents); RR=1.08, 95% CI 1.01-1.15, p-value 0.03. High-grade neuropathy (RR 1.28, 95% CI 1.06-1.54, p-value <0.01) and high-grade sensory neuropathy (RR 1.38, 95% CI 1.09-1.74, p-value <0.01) were noted more frequently with VEGFR-TKIs treatment compared against control. Conclusions: VEGFR-TKIs therapy appeared to be associated with an increased risk of neuropathy.
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
ClinicalTrials.gov study NCT02072408. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.